Utilidad de inhibidores de kinasas como nuevos agentes anticlamidiales
Chlamydia trachomatis (Ct) is the most common bacterial cause of sexually transmitted infections in the world. In women, Ct causes from acute infections such as cervicitis, endometritis, salpingitis to frequent and serious complications such as pelvic inflammatory disease, chronic pain, spontaneous...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | https://bdigital.uncu.edu.ar/fichas.php?idobjeto=14780 |
| Sumario: | Chlamydia trachomatis (Ct) is the most common bacterial cause of sexually transmitted infections in the world. In women, Ct causes from acute infections such as cervicitis, endometritis, salpingitis to frequent and serious complications such as pelvic inflammatory disease, chronic pain, spontaneous abortions, and infertility. The emergence of resistance to antibiotics such as rifamycins, macrolides, quinolones, and azithromycin, and the generation of persistent aberrant bacteria in the presence of β-lactam antibiotics, requires the development of new pharmacological tools. Since Chlamydia trachomatis is an obligate intracellular bacterium, its interaction with the host cell is fundamental for the initiation and establishment of the infection. In this project, we propose to analyze the usefulness of kinase inhibitors, particularly of the Akt / AS160 / Rab pathway, as anti-chlamydial agents. The bacterium uses this intracellular signaling pathway to capture the sphingolipids synthesized in the Golgi apparatus, which are necessary for bacterial development and replication. We will analyze the ability of kinase inhibitors to prevent invasion, limit the development of infection, prevent chronic course and improve the clinical outcome, decreasing associated tissue inflammation. It is expected that the results obtained in this project lead to the generation of new pharmacological alternatives, different from current antibiotics, that are more efficient as anti-chlamydial agents, particularly when there is antibiotic resistance or the bacteria enter a persistent state and remain for years quiescent inside the infected cells. |
|---|
